Saqib Naseer, MD, partner at Manchester, Conn.-based New England Cardiology Associates, who has been caring for patients at Manchester Memorial Hospital, claims he and three other area practices have ...

In May, the University of Vermont Medical Center sought approval to build a $129 million outpatient surgery center in South Burlington, Vt., but construction on the planned facility has now been ...

A federal judge in Florida has dismissed a whistleblower lawsuit accusing a medical practice of inflating Medicare reimbursements, citing constitutional concerns over the False Claims Act's qui tam ...

Here are five payer moves in September for ASCs to know, as reported by Becker's: 1. On Sept. 1, UnitedHealthcare rolled out its list of eligible procedures under its national prior authorization gold ...

Medical office building space in Jacksonville, Fla., is rapidly shrinking in comparison to tenant needs, according to a Sept. 30 report from the Jacksonville Business Journal.

The sister of a patient who died following a failed heart transplant at Newark (N.J.) Beth Israel Medical Center is suing the hospital and the cardiologist claiming negligence.

Here are the five most expensive ASC projects in September, as reported by Becker's: 1. St. Louis-based Mercy, the Heartland Whole Health Institute and the Alice L. Walton foundation announced a $700 ...

Here are three proactive strategies in avoiding malpractice suits, according to the report: ...

Becker's reported on 10 hospital closures in the third financial quarter of this year, and this shift may lead to an increase in volume for ASCs, as patients seek alternatives after losing access to ...

Vancouver, Wash.-based PeaceHealth is planning to acquire four medical clinics from Renton, Wash.-based Providence, according to an Oct. 3 report from The Columbian. The acquisitions will be finalized ...

HSHS St. Elizabeth’s Hospital is seeking approval for a $50 million expansion at its O'Fallon, Ill.-based medical campus, according to an Oct. 4 report from the Belleville News-Democrat.

The FDA has approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer. The FDA's approval was based on findings ...